These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29600370)

  • 1. Circulatory Tumor Cells in Esophageal Adenocarcinoma.
    Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():177-186. PubMed ID: 29600370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.
    Brungs D; Lynch D; Luk AW; Minaei E; Ranson M; Aghmesheh M; Vine KL; Carolan M; Jaber M; de Souza P; Becker TM
    World J Gastroenterol; 2018 Feb; 24(7):810-818. PubMed ID: 29467551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
    Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
    PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow Cytometric Detection of Circulating Tumor Cells Using a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR).
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Methods Mol Biol; 2017; 1634():211-217. PubMed ID: 28819854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enumeration of Circulating Tumor Cells and Disseminated Tumor Cells in Blood and Bone Marrow by Immunomagnetic Enrichment and Flow Cytometry (IE/FC).
    Magbanua MJM; Solanki TI; Ordonez AD; Hsiao F; Park JW
    Methods Mol Biol; 2017; 1634():203-210. PubMed ID: 28819853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
    Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
    BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
    Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
    Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
    Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.
    Woestemeier A; Ghadban T; Riethdorf S; Harms-Effenberger K; Konczalla L; Uzunoglu FG; Izbicki JR; Pantel K; Bockhorn M; Reeh M
    Anticancer Res; 2018 Oct; 38(10):5665-5669. PubMed ID: 30275185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas.
    Kubisch I; de Albuquerque A; Schuppan D; Kaul S; Schaich M; Stölzel U
    Oncology; 2015; 89(5):294-303. PubMed ID: 26315108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
    Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
    Kuvendjiska J; Pitman MB; Martini V; Braun C; Grebe K; Timme S; Fichtner-Feigl S; Glatz T; Schmoor C; Guenzle J; Hoeppner J; Kulemann B
    Anticancer Res; 2020 Oct; 40(10):5679-5685. PubMed ID: 32988893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology).
    Bahnassy AA; Salem SE; Mohanad M; Abulezz NZ; Abdellateif MS; Hussein M; Zekri CAN; Zekri AN; Allahloubi NMA
    Exp Mol Pathol; 2019 Feb; 106():90-101. PubMed ID: 30578762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
    de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
    Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor Cells in the Adenocarcinoma of the Esophagus.
    Gallerani G; Fabbri F
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers.
    Sclafani F; Smyth E; Cunningham D; Chau I; Turner A; Watkins D
    Clin Colorectal Cancer; 2014 Jun; 13(2):94-9. PubMed ID: 24332356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer.
    Reeh M; Effenberger KE; Koenig AM; Riethdorf S; Eichstädt D; Vettorazzi E; Uzunoglu FG; Vashist YK; Izbicki JR; Pantel K; Bockhorn M
    Ann Surg; 2015 Jun; 261(6):1124-30. PubMed ID: 25607767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.